Evolution Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-161
Closed -$80K – 813
2026
Q2
$80K Buy
161
+1
+0.6% +$480 0.03% 86
2026
Q1
$78K Hold
160
– – 0.03% 72
2025
Q4
$92K Hold
160
– – 0.04% 64
2025
Q3
$84K Hold
160
– – 0.04% 70
2025
Q2
$64K Hold
160
– – 0.03% 79
2025
Q1
$79K Hold
160
– – 0.04% 69
2024
Q4
$83K Hold
160
– – 0.05% 71
2024
Q3
$98K Hold
160
– – 0.05% 62
2024
Q2
$88K Hold
160
– – 0.05% 65
2024
Q1
$93K Hold
160
– – 0.05% 64
2023
Q4
$87K Hold
160
– – 0.06% 61
2023
Q3
$80K Hold
160
– – 0.06% 53
2023
Q2
$83K Hold
160
– – 0.06% 54
2023
Q1
$92K Hold
160
– – 0.07% 48
2022
Q4
$88K Hold
160
– – 0.07% 44
2022
Q3
$81K Hold
160
– – 0.07% 44
2022
Q2
$87K Hold
160
– – 0.07% 48
2022
Q1
$94K Hold
160
– – 0.07% 47
2021
Q4
$106K Buy
+160
New +$100K 0.08% 40

Other funds holding TMO

Evolution Advisers's TMO Position: Q3 2026 in Review

Evolution Advisers sold out of Thermo Fisher Scientific (TMO) in Q3 2026, closing a stake of 161 shares — an estimated $80K sold.

Evolution Advisers first reported a position in TMO in Q4 2021 and held it in 19 quarters. The position peaked at $106K in Q4 2021. 2,790 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Evolution Advisers reported no remaining Thermo Fisher Scientific position as of Q3 2026 after selling out during the quarter.
  • Evolution Advisers sold 161 Thermo Fisher Scientific shares in Q3 2026, an estimated $80K.
  • Evolution Advisers first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 19 quarters.
  • Evolution Advisers's Thermo Fisher Scientific position peaked at $106K in Q4 2021.
  • 2,790 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Evolution Advisers's 13F filing for Q3 2026, filed 6 Nov 2026.